Catalyst Wire Dossier Catalyst Wire Dossier

Beclomethasone dipropionate + Salbutamol fixed-dose combination inhaler

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beclomethasone dipropionate + Salbutamol fixed-dose combination inhaler, covering 2017-03-30 to 2017-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma [Phase 3]

See pricing